Company aims to make all measurements, protocols and therapies in Johnson’s longevity regimen ‘easy and accessible’ for others.
Consumer longevity company Blueprint has secured $60 million in funding from a host of high-profile investors. Seasoned investors including Naval Ravikant, Balaji Srinivasan and the Winklevoss brothers joined the likes of Kim Kardashian, Logan Paul and Paris Hilton, as an eclectic mix of some 50 individuals joined forces to back the company’s personalized approach to longevity.
Created by tech entrepreneur-turned-biohacker Bryan Johnson, Blueprint emerged from Johnson’s own highly regimented health protocol developed over several years with a team of scientists and doctors. What began as a personal health regimen has now evolved into a well-funded startup designed to productize the approach for a broader audience.
“After my team and I built a protocol for me, my friends and family asked if they could get access too,” said Johnson in a post on X. “Then their friends and family asked and I said yes again. The circle kept on expanding until we stumbled into Blueprint becoming a company.”
A controversial figure in longevity circles, Johnson began his ambitious quest to reduce his own biological aging around 2021. Using comprehensive data analytics and medical diagnostics to guide his daily routine, his approach includes strict diets, exercise, sleep schedules and the intake of over 100 supplements daily. The goal is to minimize cellular deterioration and optimize bodily functions, with Johnson aiming to effectively “turn back the clock” on aging.
Moving forward, Blueprint’s mission is to translate this personal longevity protocol into a system that anyone can follow. Johnson said the platform will combine medical testing, nutrition, prescriptions and advanced therapies with an AI health companion designed to simplify decision-making.
“We’re making my protocol accessible to everyone,” he said. “To replicate everything including the measurements, protocols, therapies – and make it easy and accessible for others to do in a community.”
How times change. Just a few months ago, Johnson hit the headlines after an interview with Wired, where he admitted he was “so close” to either shutting down Blueprint or selling it.
“Since then, I’ve explored the options,” said Johnson in a statement, shortly after the article came out. “We’re going all in. We’re making Blueprint accessible and impactful for everyone. To replicate everything in my protocol – all the measurements, protocols, therapies – and make it easy and accessible for others to do in community.”
As part of Blueprint’s next phase, Gyre Renwick, formerly of Modern Health, Google Health and Lyft Healthcare, has joined Johnson and co-founder Kate Tolo as the company’s CEO. Johnson will continue to steer Blueprint’s vision and strategy, focusing on expanding its philosophical foundation through his “Don’t Die” initiative.
“In this next chapter, I am doubling down on Blueprint and Don’t Die,” said Johnson. “I’m all in. Gyre will run the business and I will focus on vision, strategy, and birthing Don’t Die into the world.”
